Top Markets
Coin of the day
Borregaard ASA Borregaard ASA

Borregaard ASA

BRG
Rangering i aksjer #7277
Borregaard ASA, established in 2012 and headquartered in Sarpsborg, Norway, is... Borregaard ASA, established in 2012 and headquartered in Sarpsborg, Norway, is a global enterprise focused on the development, production, and marketing of specialized biomaterials, biochemicals, and biofuels. Its market presence extends across Norway, the broader European region, the United States, Asia, and various other international territories. The company's operations are structured around three distinct divisions: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment provides biopolymers crucial for numerous applications, including agrochemicals, battery manufacturing, industrial binding, and construction. This division also supplies biovanillin to the flavor and fragrance industries, as well as the food and beverage sector. In the BioMaterials segment, Borregaard offers specialty cellulose, utilized as a raw material in the production of items such as cellulose ethers, cellulose acetate, and other specialized products. It further manufactures cellulose fibrils for diverse industrial purposes. Lastly, the Fine Chemicals segment delivers fine chemical intermediates, particularly for contrast agents, in addition to bioethanol.
Aksjekurs
$16.52
Markedsverdi
$1.65B
Endring (1 dag)
0.77%
Endring (1 år)
-19.39%
Land
NO
Handel Borregaard ASA (BRG)
Inntekter for Borregaard ASA (BRG)
Inntekter i 2026 TTM: 0
Ifølge Borregaard ASA sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Borregaard ASA fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$9.38B -
GB
- -
FR
$3.49B -
US
$2.63B -
US
$-82.10M -
US